BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20684140)

  • 1. Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle.
    Feldman SR
    J Drugs Dermatol; 2010 Aug; 9(8):908-11. PubMed ID: 20684140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis: improving adherence to topical therapy.
    Feldman SR; Horn EJ; Balkrishnan R; Basra MK; Finlay AY; McCoy D; Menter A; van de Kerkhof PC;
    J Am Acad Dermatol; 2008 Dec; 59(6):1009-16. PubMed ID: 18835062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception of disease and doctor-patient relationship experienced by patients with psoriasis: a questionnaire-based study.
    Linder D; Dall'olio E; Gisondi P; Berardesca E; Gennaro ED; Pennella AR; Giannetti A; Peserico A; Girolomoni G
    Am J Clin Dermatol; 2009; 10(5):325-30. PubMed ID: 19658445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing patient adherence for optimal outcomes in psoriasis.
    Bewley A; Page B
    J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():9-14. PubMed ID: 21507078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
    Zivkovich AH; Feldman SR
    J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical treatment adherence for psoriasis].
    Halioua B
    Rev Prat; 2012 Feb; 62(2):156-9. PubMed ID: 22408849
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations.
    Uhlenhake EE; Kurkowski D; Feldman SR
    J Dermatolog Treat; 2010 Jan; 21(1):6-12. PubMed ID: 19579071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to treatment in patients with psoriasis.
    Richards HL; Fortune DG; Griffiths CE
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):370-9. PubMed ID: 16643132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adherence of local (and general) treatments in psoriasis].
    Cribier B
    Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S13-7. PubMed ID: 22305281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease burden and treatment adherence in psoriasis patients.
    Feldman SR
    Cutis; 2013 Nov; 92(5):258-63. PubMed ID: 24343214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical steroids and corticophobia.
    Belloni Fortina A; Neri L
    G Ital Dermatol Venereol; 2013 Dec; 148(6):651-4. PubMed ID: 24442046
    [No Abstract]   [Full Text] [Related]  

  • 12. 'Coral reef' psoriasis: a marker of resistance to topical treatment.
    Feldman SR; Brown KL; Heald P
    J Dermatolog Treat; 2008; 19(5):257-8. PubMed ID: 18608734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
    Brown KK; Rehmus WE; Kimball AB
    J Am Acad Dermatol; 2006 Oct; 55(4):607-13. PubMed ID: 17010739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The right dose in the right place: an overview of current prescription, instruction and application modalities for topical psoriasis treatments.
    Savary J; Ortonne JP; Aractingi S
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():14-7. PubMed ID: 16274407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a single educative intervention in patients with chronic plaque psoriasis.
    Lora V; Gisondi P; Calza A; Zanoni M; Girolomoni G
    Dermatology; 2009; 219(4):316-21. PubMed ID: 19844077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' educational needs about topical treatments for psoriasis.
    Martin SL; McGoey ST; Bebo BF; Feldman SR
    J Am Acad Dermatol; 2013 Jun; 68(6):e163-8. PubMed ID: 22682885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of dermatologist in adherence to treatment].
    Misery L
    Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S18-21. PubMed ID: 22305282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalp psoriasis: an overview of the disease and available therapies.
    Crowley J
    J Drugs Dermatol; 2010 Aug; 9(8):912-8. PubMed ID: 20684141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to adalimumab in patients with moderate to severe psoriasis.
    West C; Narahari S; O'Neill J; Davis S; Huynh M; Clark A; Boles A; Feldman SR
    Dermatol Online J; 2013 May; 19(5):18182. PubMed ID: 24011280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.